Exact Mass: 232.095551
Exact Mass Matches: 232.095551
Found 500 metabolites which its exact mass value is equals to given mass value 232.095551,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Nalidixic Acid
Nalidixic Acid is only found in individuals that have used or taken this drug. It is a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum. It is an inhibitor of the A subunit of bacterial DNA gyrase. [PubChem]Evidence exists for Nalidixic acid that its active metabolite, hydroxynalidixic acid, binds strongly, but reversibly, to DNA, interfering with synthesis of RNA and, consequently, with protein synthesis. CONFIDENCE standard compound; INTERNAL_ID 840; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3554; ORIGINAL_PRECURSOR_SCAN_NO 3553 CONFIDENCE standard compound; INTERNAL_ID 840; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7969; ORIGINAL_PRECURSOR_SCAN_NO 7967 CONFIDENCE standard compound; INTERNAL_ID 840; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3567; ORIGINAL_PRECURSOR_SCAN_NO 3565 CONFIDENCE standard compound; INTERNAL_ID 840; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8010; ORIGINAL_PRECURSOR_SCAN_NO 8008 CONFIDENCE standard compound; INTERNAL_ID 840; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7993; ORIGINAL_PRECURSOR_SCAN_NO 7988 CONFIDENCE standard compound; INTERNAL_ID 840; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7958; ORIGINAL_PRECURSOR_SCAN_NO 7956 CONFIDENCE standard compound; INTERNAL_ID 840; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8025; ORIGINAL_PRECURSOR_SCAN_NO 8023 CONFIDENCE standard compound; INTERNAL_ID 840; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8010; ORIGINAL_PRECURSOR_SCAN_NO 8009 J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic C254 - Anti-Infective Agent > C255 - Urinary Anti-Infective Agent D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents KEIO_ID N067; [MS2] KO009130 D004791 - Enzyme Inhibitors KEIO_ID N067 Nalidixic acid, a quinolone antibiotic, is effective against both gram-positive and gram-negative bacteria. Nalidixic acid acts in a bacteriostatic manner in lower concentrations and is bactericidal in higher concentrations. Nalidixic acid inhibits a subunit of DNA gyrase and topoisomerase IV and reversibly blocks DNA replication in susceptible bacteria[1]. Nalidixic acid, a quinolone antibiotic, is effective against both gram-positive and gram-negative bacteria. Nalidixic acid acts in a bacteriostatic manner in lower concentrations and is bactericidal in higher concentrations. Nalidixic acid inhibits a subunit of DNA gyrase and topoisomerase IV and reversibly blocks DNA replication in susceptible bacteria[1].
FLUOMETURON
C10H11F3N2O (232.08234319999997)
CONFIDENCE standard compound; INTERNAL_ID 921; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8414; ORIGINAL_PRECURSOR_SCAN_NO 8413 CONFIDENCE standard compound; INTERNAL_ID 921; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8483; ORIGINAL_PRECURSOR_SCAN_NO 8479 CONFIDENCE standard compound; INTERNAL_ID 921; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8454; ORIGINAL_PRECURSOR_SCAN_NO 8453 CONFIDENCE standard compound; INTERNAL_ID 921; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8416; ORIGINAL_PRECURSOR_SCAN_NO 8415 CONFIDENCE standard compound; INTERNAL_ID 921; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8468; ORIGINAL_PRECURSOR_SCAN_NO 8466 CONFIDENCE standard compound; INTERNAL_ID 921; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4168; ORIGINAL_PRECURSOR_SCAN_NO 4167 CONFIDENCE standard compound; INTERNAL_ID 921; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4190; ORIGINAL_PRECURSOR_SCAN_NO 4189 CONFIDENCE standard compound; INTERNAL_ID 921; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4172; ORIGINAL_PRECURSOR_SCAN_NO 4171 CONFIDENCE standard compound; INTERNAL_ID 921; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8464; ORIGINAL_PRECURSOR_SCAN_NO 8462 CONFIDENCE standard compound; INTERNAL_ID 921; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4199; ORIGINAL_PRECURSOR_SCAN_NO 4198 CONFIDENCE standard compound; INTERNAL_ID 921; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4184; ORIGINAL_PRECURSOR_SCAN_NO 4183 CONFIDENCE standard compound; INTERNAL_ID 921; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4155; ORIGINAL_PRECURSOR_SCAN_NO 4154 CONFIDENCE standard compound; EAWAG_UCHEM_ID 3709
Phenobarbital
Phenobarbital is only found in individuals that have used or taken this drug. It is a barbituric acid derivative that acts as a nonselective central nervous system depressant.Phenobarbital acts on GABAA receptors, increasing synaptic inhibition. This has the effect of elevating seizure threshold and reducing the spread of seizure activity from a seizure focus. Phenobarbital may also inhibit calcium channels, resulting in a decrease in excitatory transmitter release. The sedative-hypnotic effects of phenobarbital are likely the result of its effect on the polysynaptic midbrain reticular formation, which controls CNS arousal. Phenobarbital appears as odorless white crystalline powder or colorless crystals. A saturated aqueous solution is acid to litmus (approximately pH 5). Slightly bitter taste. (NTP, 1992) Phenobarbital is a member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and phenyl groups. It has a role as an anticonvulsant, a sedative, an excitatory amino acid antagonist and a drug allergen. Phenobarbital is a DEA Schedule IV controlled substance. Substances in the DEA Schedule IV have a low potential for abuse relative to substances in Schedule III. It is a Depressants substance. A barbituric acid derivative that acts as a nonselective central nervous system depressant. It promotes binding to inhibitory gamma-aminobutyric acid subtype receptors, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations. Phenobarbital is a barbiturate that is widely used as a sedative and an antiseizure medication. Phenobarbital has been linked to rare instances of idiosyncratic liver injury that can be severe and even fatal. Phenobarbital is a long-acting barbituric acid derivative with antipsychotic property. Phenobarbital binds to and activates the gamma-aminobutyric acid (GABA)-A receptor, thereby mimicking the inhibitory actions of GABA in the brain. The activation effects of the phenobarbital-receptor-ionophore complex include increased frequency of chloride channel openings, membrane hyperpolarization and ultimately synaptic inhibition and decreased neuronal excitability. In addition, this agent inhibits glutamate induced depolarization. Phenobarbital is only found in individuals that have used or taken this drug. It is a barbituric acid derivative that acts as a nonselective central nervous system depressant. It promotes binding to inhibitory gamma-aminobutyric acid subtype receptors, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations. [PubChem] Phenobarbital acts on GABAA receptors, increasing synaptic inhibition. This has the effect of elevating seizure threshold and reducing the spread of seizure activity from a seizure focus. Phenobarbital may also inhibit calcium channels, resulting in a decrease in excitatory transmitter release. The sedative-hypnotic effects of phenobarbital are likely the result of its effect on the polysynaptic midbrain reticular formation, which controls CNS arousal. A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.
N2-Succinyl-L-ornithine
N2-Succinyl-L-ornithine is a substrate for Ornithine aminotransferase (mitochondrial). It can be found in Escherichia (UniProt). N2-Succinyl-L-ornithine is a substrate for Ornithine aminotransferase (mitochondrial). [HMDB]
Cryptolepine
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents
4-(Glutamylamino) butanoate
4-(Glutamylamino) butanoate is a polyamine that is an intermediate in putrescine degradation II. Polyamines (the most common of which are putrescine , spermidine , and spermine ), a group of positively charged small molecules present in virtually all living organisms, have been implicated in many biological processes, including binding to nucleic acids, stabilizing membranes, and stimulating several enzymes. Although polyamines are clearly necessary for optimal cell growth, a surplus of polyamines can cause inhibition of growth and protein synthesis, and thus a balance is desired between the production and breakdown of polyamines. In putrescine degradation II, 4-(Glutamylamino) butanoate is a substrate for gamma-glutamyl-gamma-aminobutyrate hydrolase (puuD) and can be generated from the hydrolysis of gamma-glutamyl-gamma-aminobutyraldehyde. [HMDB] 4-(Glutamylamino) butanoate is a polyamine that is an intermediate in putrescine degradation II. Polyamines (the most common of which are putrescine , spermidine , and spermine ), a group of positively charged small molecules present in virtually all living organisms, have been implicated in many biological processes, including binding to nucleic acids, stabilizing membranes, and stimulating several enzymes. Although polyamines are clearly necessary for optimal cell growth, a surplus of polyamines can cause inhibition of growth and protein synthesis, and thus a balance is desired between the production and breakdown of polyamines. In putrescine degradation II, 4-(Glutamylamino) butanoate is a substrate for gamma-glutamyl-gamma-aminobutyrate hydrolase (puuD) and can be generated from the hydrolysis of gamma-glutamyl-gamma-aminobutyraldehyde.
1-Methoxypyrene
This compound belongs to the family of Pyrenes. These are compounds containing a pyrene moiety, which consists four fused benzene rings, resulting in a flat aromatic system.
Ethyl 5-oxo-1-phenyl-2-pyrazoline-3-carboxylate
CONFIDENCE standard compound; INTERNAL_ID 884; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3866; ORIGINAL_PRECURSOR_SCAN_NO 3864 CONFIDENCE standard compound; INTERNAL_ID 884; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3825; ORIGINAL_PRECURSOR_SCAN_NO 3823 CONFIDENCE standard compound; INTERNAL_ID 884; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3826; ORIGINAL_PRECURSOR_SCAN_NO 3824 CONFIDENCE standard compound; INTERNAL_ID 884; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3853; ORIGINAL_PRECURSOR_SCAN_NO 3850 CONFIDENCE standard compound; INTERNAL_ID 884; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3819; ORIGINAL_PRECURSOR_SCAN_NO 3818 CONFIDENCE standard compound; INTERNAL_ID 884; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3819; ORIGINAL_PRECURSOR_SCAN_NO 3816 CONFIDENCE standard compound; INTERNAL_ID 884; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7958; ORIGINAL_PRECURSOR_SCAN_NO 7956 CONFIDENCE standard compound; INTERNAL_ID 884; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7993; ORIGINAL_PRECURSOR_SCAN_NO 7988 CONFIDENCE standard compound; INTERNAL_ID 884; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8010; ORIGINAL_PRECURSOR_SCAN_NO 8008 CONFIDENCE standard compound; INTERNAL_ID 884; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8025; ORIGINAL_PRECURSOR_SCAN_NO 8023 CONFIDENCE standard compound; INTERNAL_ID 884; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8010; ORIGINAL_PRECURSOR_SCAN_NO 8009
Marindinin
Marindinin is found in beverages. Marindinin is found in the roots of kava (Piper methysticum). FDA advises against use of kava in food due to potential risk of severe liver damage (2002 Dihydrokavain is one of the six major kavalactones found in the kava plant; appears to contribute significantly to the anxiolytic effects of kava, based on a study in chicks. Dihydrokavain is one of the six major kavalactones found in the kava plant; appears to contribute significantly to the anxiolytic effects of kava, based on a study in chicks.
3-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]prop-2-enoic acid
Pterosin E
Constituent of Pteridium aquilinum (bracken fern) leaves. Pterosin E is found in green vegetables and root vegetables. Pterosin E is found in green vegetables. Pterosin E is a constituent of Pteridium aquilinum (bracken fern) leaves.
Valylaspartic acid
Valylaspartic acid is a dipeptide composed of valine and aspartic acid. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.
Aspartyl-Valine
Aspartyl-Valine is a dipeptide composed of aspartate and valine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.
Hydroxyprolyl-Threonine
Hydroxyprolyl-Threonine is a dipeptide composed of hydroxyproline and threonine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.
Threonylhydroxyproline
Threonylhydroxyproline is a dipeptide composed of threonine and hydroxyproline. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.
L-N-(3-Carboxypropyl)glutamine
L-N-(3-Carboxypropyl)glutamine is found in root vegetables. L-N-(3-Carboxypropyl)glutamine is a constituent of beet
Glycerol 1-propanoate diacetate
Glycerol 1-propanoate diacetate is classified as a Natural Food Constituent (code WA) in the DFC
Tetrahydrofurfuryl cinnamate
Tetrahydrofurfuryl cinnamate is a flavouring agent with sweet vinous odou Flavouring agent with sweet vinous odour
gamma-Glutamyl-2-aminobutyric acid
gamma-Glutamyl-2-aminobutyric acid, also known as gamma-Glu-Abu, belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. gamma-Glutamyl-2-aminobutyric acid has been identified in blood (PMID: 28059425).
Indole-3-acetylglycine
Indole-3-acetylglycine also known as N-(3-indolylacetyl)glycine, belongs to the class of organic compounds known as N-acyl-alpha amino acids. N-acyl-alpha amino acids are compounds containing an alpha-amino acid which bears an acyl group at its terminal nitrogen atom. Indole-3-acetylglycine has been identified in urine (PMID: 31396400).
Camphorsulfonic acid
C10H16O4S (232.07692559999998)
Dazoxiben
C78275 - Agent Affecting Blood or Body Fluid > C29750 - Thrombolytic Agent D004791 - Enzyme Inhibitors
Marindinin
Dihydrokavain is a member of 2-pyranones and an aromatic ether. Dihydrokawain is a natural product found in Piper methysticum, Alnus sieboldiana, and other organisms with data available. See also: Piper methysticum root (part of). Dihydrokavain is one of the six major kavalactones found in the kava plant; appears to contribute significantly to the anxiolytic effects of kava, based on a study in chicks. Dihydrokavain is one of the six major kavalactones found in the kava plant; appears to contribute significantly to the anxiolytic effects of kava, based on a study in chicks.
2HP328XN7C
Fraxinellone is a member of 2-benzofurans. Fraxinellone is a natural product found in Raulinoa echinata, Melia azedarach, and other organisms with data available. Fraxinellone is isolated from the root bark of the Rutaceae plant, Dictamnus dasycarpus. Fraxinellone is a PD-L1 inhibitor and inhibits HIF-1α protein synthesis without affecting HIF-1α protein degradation. Fraxinellone has the potential to be a valuable candidate for cancer treatment by targeting PD-L1[1]. Fraxinellone is isolated from the root bark of the Rutaceae plant, Dictamnus dasycarpus. Fraxinellone is a PD-L1 inhibitor and inhibits HIF-1α protein synthesis without affecting HIF-1α protein degradation. Fraxinellone has the potential to be a valuable candidate for cancer treatment by targeting PD-L1[1]. Fraxinellone is isolated from the root bark of the Rutaceae plant, Dictamnus dasycarpus. Fraxinellone is a PD-L1 inhibitor and inhibits HIF-1α protein synthesis without affecting HIF-1α protein degradation. Fraxinellone has the potential to be a valuable candidate for cancer treatment by targeting PD-L1[1].
3-Furan-3-yl-3a,7-dimethyl-3a,4,5,6-tetrahydro-3H-isobenzofuran-1-one
1-Pyrenemethanol
http://casmi-contest.org/challenges-cat1-2.shtml; CASMI2012 LC Challenge 11
N-Cyclohexyl-1,3-benzothiazol-2-amine
C13H16N2S (232.10341359999998)
(3Z,6Z)-O-Sulfate-3,6,9-Decatrien-1-ol
C10H16O4S (232.07692559999998)
6-Deoxy-2-O-methyl-3-C-methuyltalose, 9CI-beta-L-Pyranose-form-Me glycoside, 2,4-di-Ac
3-(isobutyryloxymethyl)-6-methylbenzofuran|O-(2-Methylpropanoyl)-6-Methyl-3-benzofuranmethanol
5-ethylidene-2-hydroxy-2-hydroxymethyl-3-methylhexane-dioic acid|isatinecic acid|Retronecinsaeure|Retronecinsaeure (14Cn)|Retronecinsaeure <14Cn>
Fraxinellone
Fraxinellone is isolated from the root bark of the Rutaceae plant, Dictamnus dasycarpus. Fraxinellone is a PD-L1 inhibitor and inhibits HIF-1α protein synthesis without affecting HIF-1α protein degradation. Fraxinellone has the potential to be a valuable candidate for cancer treatment by targeting PD-L1[1]. Fraxinellone is isolated from the root bark of the Rutaceae plant, Dictamnus dasycarpus. Fraxinellone is a PD-L1 inhibitor and inhibits HIF-1α protein synthesis without affecting HIF-1α protein degradation. Fraxinellone has the potential to be a valuable candidate for cancer treatment by targeting PD-L1[1]. Fraxinellone is isolated from the root bark of the Rutaceae plant, Dictamnus dasycarpus. Fraxinellone is a PD-L1 inhibitor and inhibits HIF-1α protein synthesis without affecting HIF-1α protein degradation. Fraxinellone has the potential to be a valuable candidate for cancer treatment by targeting PD-L1[1].
(6R,7R)-tetradeca-4E,12E-diene-6,7-diol-8,10-diyneal
Me glycoside,2,3-O-isopropylidene,Me ester-beta-D-Furanose-Riburonic acid
1-(2-hydroxy-4-methoxy-5-methylphenyl)-2,4-E,E-hexadien-1-one|1-(2-hydroxy-4-methoxy-5-methylphenyl)-E,E-2,4-hexadien-1-one
(8alpha,10beta)-form-15-Nor-4-oxo-1(5),11(13)-guaiadien-12,8-olide
3-Hydroxy-5-methoxy-2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-one
(2E,4E)-1-(2,6-dihydroxy-3,5-dimethyl-phenyl)hexa-2,4-dien-1-one
(-)-(3S)-7-hydroxy-2,3,4,9-tetrahydro-1H-beta-carboline-3-carboxylic acid|brunnein C
(2E)-3-[(2S)-2,3-dihydro-2-(2-hydroxypropan-2-yl)-1-benzofuran-5-yl]prop-2-enal|(S)-demethoxywutaiensal
(2E)-3-[(3R)-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-chromen-6-yl]prop-2-enal|(R)-wutaipyranol A
(-)-2,3-dihydro-7-hydroxy-6,8-dimethyl-2-[(E)-prop-1-enyl]-chroman-4-one
2-hydroxy-1-((S)-2-(prop-1-en-2-yl)-2,3-dihydrobenzofuran-5-yl)propan-1-one|phenostereum A
(E)-3-(2,2-dimethylchroman-6-yl)-2-propenoic acid|(E)-3-(2,2-dimethylchroman-6-yl)acrylic acid|3-[(2H)-2,2-dimethyl-3,4-dihydrobenzopyran-6-yl]-2E-propenoic acid|Drupacin|dupracine
di-(3-deoxy-D-glycero-pentulose) 1,2:2,1 dianhydride
4-Acetyl-2,3-dihydro-2-isopropenyl-5-methoxybenzofuran
3-acetoxy-7-methyl-1,3-dihydro-benzo[e][1,4]diazepin-2-one
4-oxo-5(6),11-eudesmadien-8,12-olide|noralantolactone
todralazine
C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents CONFIDENCE standard compound; INTERNAL_ID 1276; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4755; ORIGINAL_PRECURSOR_SCAN_NO 4753 CONFIDENCE standard compound; INTERNAL_ID 1276; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4752; ORIGINAL_PRECURSOR_SCAN_NO 4751 CONFIDENCE standard compound; INTERNAL_ID 1276; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4779; ORIGINAL_PRECURSOR_SCAN_NO 4778 CONFIDENCE standard compound; INTERNAL_ID 1276; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4772; ORIGINAL_PRECURSOR_SCAN_NO 4769 CONFIDENCE standard compound; INTERNAL_ID 1276; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4779; ORIGINAL_PRECURSOR_SCAN_NO 4777
2-[(2-methylsulfanyl)pentyl]maleate
C10H16O4S (232.07692559999998)
Nalidixic acid
A monocarboxylic acid comprising 1,8-naphthyridin-4-one substituted by carboxylic acid, ethyl and methyl groups at positions 3, 1, and 7, respectively. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic C254 - Anti-Infective Agent > C255 - Urinary Anti-Infective Agent D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D004791 - Enzyme Inhibitors Nalidixic acid, a quinolone antibiotic, is effective against both gram-positive and gram-negative bacteria. Nalidixic acid acts in a bacteriostatic manner in lower concentrations and is bactericidal in higher concentrations. Nalidixic acid inhibits a subunit of DNA gyrase and topoisomerase IV and reversibly blocks DNA replication in susceptible bacteria[1]. Nalidixic acid, a quinolone antibiotic, is effective against both gram-positive and gram-negative bacteria. Nalidixic acid acts in a bacteriostatic manner in lower concentrations and is bactericidal in higher concentrations. Nalidixic acid inhibits a subunit of DNA gyrase and topoisomerase IV and reversibly blocks DNA replication in susceptible bacteria[1].
(2E,4E)-1-(2,4-dihydroxy-3,5-dimethylphenyl)hexa-2,4-dien-1-one
N-Cyclohexyl-2-benzothiazol-amine
C13H16N2S (232.10341359999998)
CONFIDENCE standard compound; INTERNAL_ID 2879 CONFIDENCE standard compound; INTERNAL_ID 8847
Dihydrokavain
Dihydrokavain is one of the six major kavalactones found in the kava plant; appears to contribute significantly to the anxiolytic effects of kava, based on a study in chicks. Dihydrokavain is one of the six major kavalactones found in the kava plant; appears to contribute significantly to the anxiolytic effects of kava, based on a study in chicks.
(4S,5Z,6S)-4-(2-methoxy-2-oxoethyl)-5-[2-[(E)-3-phenylprop-2-enoyl]oxyethylidene]-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4H-pyran-3-carboxylic acid
phenobarbital
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D018377 - Neurotransmitter Agents > D018683 - Excitatory Amino Acid Agents > D018691 - Excitatory Amino Acid Antagonists N - Nervous system > N03 - Antiepileptics > N03A - Antiepileptics > N03AA - Barbiturates and derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C67084 - Barbiturate D065693 - Cytochrome P-450 Enzyme Inducers > D065695 - Cytochrome P-450 CYP2B6 Inducers D065693 - Cytochrome P-450 Enzyme Inducers > D065701 - Cytochrome P-450 CYP3A Inducers D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants
ethyl 5-oxo-1-phenyl-4H-pyrazole-3-carboxylate
CONFIDENCE standard compound; INTERNAL_ID 884; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7969; ORIGINAL_PRECURSOR_SCAN_NO 7967
3,4,5,6-tetrahydro-6,6-dimethyl-spiro[isobenzofuran-1(3H),2-[2H]pyran]-3-one
D-Camphorsulfonic acid
C10H16O4S (232.07692559999998)
C1892 - Chemopreventive Agent > C851 - Sunscreen
Asp-val
A dipeptide formed from L-alpha-aspartyl and L-valine residues.
Val-asp
A dipeptide formed from L-valine and L-aspartic acid residues.
Pyrrolo[2,1-b]quinazolin-9(1H)-one,2,3-dihydro-3-hydroxy-5-methoxy-
3-[Dimethoxy(methyl)silyl]propyl methacrylate
C10H20O4Si (232.11308000000002)
1-Phthalazineaceticacid, 3,4-dihydro-4-oxo-, ethyl ester
6-CHLORO-3-(1,2,3,6-TETRAHYDRO-PYRIDIN-4-YL)-1H-INDOLE
2-(2-AMINO-PHENYL)-OXAZOLE-4-CARBOXYLIC ACID ETHYL ESTER
4-(4-TERT-BUTYLPHENYL)THIAZOL-2-YLAMINE
C13H16N2S (232.10341359999998)
ETHYL5-AMINO-1-(PYRIDIN-2-YL)-1H-PYRAZOLE-4-CARBOXYLATE
Ethyl 7-methyl-4-oxo-4H-pyrido(1,2-a)pyrimidine-3-carboxylate
FURAN-2-CARBOXYLIC ACID (4-AMINO-2-METHOXY-PHENYL)-AMIDE
1-(4-Trifluoromethylpyrimidin-2-yl)piperazine
C9H11F3N4 (232.09357619999997)
1H-Indole,5,7-difluoro-2,3-dihydro-2-(3-pyridinyl)-(9CI)
ETHYL 2-METHYL-5-OXO-5,6-DIHYDRO[1,6]NAPHTHYRIDINE-3-CARBOXYLATE
5-(4-Methoxyphenyl)-2-Methylpyrazole-3-carboxylic acid
4-(4-oxo-3,4-dihydroquinazolin-2-yl)butanoic acid(SALTDATA: FREE)
4-[4-(2-methylpropyl)phenyl]-1,3-thiazol-2-amine
C13H16N2S (232.10341359999998)
5-methyl-4-(4-propan-2-ylphenyl)-1,3-thiazol-2-amine
C13H16N2S (232.10341359999998)
ETHYL 2-(5-PHENYL-2H-1,2,3,4-TETRAAZOL-2-YL)ACETATE
5-methyl-4-(4-propylphenyl)-1,3-thiazol-2-amine
C13H16N2S (232.10341359999998)
1H-Pyrazole-4-carboxylicacid, 2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-
6,6-Dimethyl-3-(trifluoromethyl)-6,7-dihydro-1H-indazol-4(5H)-one
C10H11F3N2O (232.08234319999997)
Cyclohexanecarboxylic acid, 4-oxo-, phenylmethyl ester
4-[4-(2-BUTYL)PHENYL]THIAZOL-2-YLAMINE
C13H16N2S (232.10341359999998)
2-(4-methoxyphenyl)-5-methyl-1H-imidazole-4-carboxylic acid
(R)-6-Benzyloxymethyl-4-methyl-5,6-dihydro-pyran-2-one
3-(3,4-DIMETHOXYPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE
(S)-2-[BENZYL-(3-CHLORO-2-HYDROXY-PROPYL)-AMINO]-N-(4-BENZYLOXY-PHENYL)-ACETAMIDE
L(-)-Camphorsulfonic acid
C10H16O4S (232.07692559999998)
5-(4-METHOXYPHENYL)-1-METHYL-1H-PYRAZOLE-3-CARBOXYLIC ACID
5-(3-Methoxy-phenyl)-2H-pyrazole-3-carboxylic acid methyl ester
methyl 3-[[(4R)-2-methyl-1,3-thiazolidine-4-carbonyl]amino]propanoate
4-(4-Fluorophenyl)-6-isopropylpyrimidin-2-ol
C13H13FN2O (232.10118599999998)
Pyrimido[4,5-b]quinoline-2(1H)-thione, 4-amino-6,7,8,9-tetrahydro- (9CI)
C11H12N4S (232.07826319999998)
Molinazone
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent
[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]boronic acid
C11H13BN2O3 (232.10191780000002)
tert-butyl 3-hydroxy-3-(nitromethyl)azetidine-1-carboxylate
4-[6-(Trifluoromethyl)-2-pyridinyl]morpholine
C10H11F3N2O (232.08234319999997)
2-(3-AMINO-PHENYL)-OXAZOLE-4-CARBOXYLIC ACID ETHYL ESTER
2-Benzoxepin-1,3-dione,4,5-dihydro-4,4,7,9-tetramethyl-
(4-(2-(1H-PYRAZOL-1-YL)ETHOXY)PHENYL)BORONIC ACID
C11H13BN2O3 (232.10191780000002)
(5-ACETOXY-1,3-OXATHIOLAN-2-YL)METHYL BUTYRATE
C10H16O4S (232.07692559999998)
4-(1-Piperazinyl)-6-(trifluoromethyl)pyrimidine
C9H11F3N4 (232.09357619999997)
3-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]propanoic acid
5-ISOPROPYL-3-METHYLTHIO-1-PHENYL-1H-PYRAZOLE
C13H16N2S (232.10341359999998)
2-(4-METHOXY-PHENYL)-5-METHYL-2H-PYRAZOLE-3-CARBOXYLIC ACID
3-[3-(3-methylphenyl)-1,2,4-oxadiazol-5-yl]propanoic acid
3-ETHYL-4-OXO-3,4-DIHYDRO-PHTHALAZINE-1-CARBOXYLIC ACID METHYL ESTER
ethyl 4-hydroxy-7-methyl-1,8-naphthyridine-3-carboxylate
N-(1-cyanocyclopentyl)-3-fluorobenzamide
C13H13FN2O (232.10118599999998)
3-(4-FLUOROBENZYL)-5,6,7,8-TETRAHYDRO-[1,2,4]TRIAZOLO[4,3-A]PYRAZINE
4-OXO-1,2,3,3A,4,5-HEXAHYDRO-PYRROLO[1,2-A]QUINOXALINE-7-CARBOXYLIC ACID
Ethyl 3-(4-methylphenyl)-1,2,4-oxadiazole-5-carboxylate
ETHYL5-AMINO-1-(PYRIDIN-4-YL)-1H-PYRAZOLE-4-CARBOXYLATE
N-(1-cyanocyclopentyl)-2-fluorobenzamide
C13H13FN2O (232.10118599999998)
(4-(2-(1H-Imidazol-1-yl)ethoxy)phenyl)boronic acid
C11H13BN2O3 (232.10191780000002)
3-ACETYLAMINO-5-METHYL-1H-INDOLE-2-CARBOXYLIC ACID
BENZENEACETIC ACID, 4-(CYCLOPROPYLCARBONYL)-A,A-DIMETHYL-
(E)-3-(2-Formylphenyl)-2-propenoic acid 1,1-dimethyl ethyl ester
Cyclohexane, 1-(bromomethyl)-4-(1,1-dimethylethyl)
(2-OXO-3-PYRIDIN-4-YL-PROPYL)-CARBAMICACIDTERT-BUTYLESTER
1-(4-METHOXYPHENYL)-5-METHYL-1H-PYRAZOLE-4-CARBOXYLICACID
3-(ETHOXYCARBONYL)-2-METHYLQUINOXALIN-1-IUM-1-OLATE
Carbamimidothioic acid, N,N-bis[(ethylamino)carbonyl]-, methyl ester
C8H16N4O2S (232.09939160000002)
5-Methoxy-7-trifluoromethyl-1,2,3,4-tetrahydro-[2,6]naphthyridine
C10H11F3N2O (232.08234319999997)
(3-((1H-1,2,4-TRIAZOL-3-YL)CARBAMOYL)PHENYL)BORONIC ACID
Boc-D-Asparagine
(R)-4-Amino-2-((tert-butoxycarbonyl)amino)-4-oxobutanoic acid is an asparagine derivative[1].
methyl (5-hydroxy-1-phenyl-1H-pyrazol-3-yl)acetate
(4-((Furan-2-ylmethoxy)methyl)phenyl)boronic acid
C12H13BO4 (232.09068480000002)
5-(4-Methoxy-phenyl)-2H-pyrazole-3-carboxylic acid methyl ester
1,2,3,4-TETRAHYDRO-6-METHYL-2-OXO-4-PHENYL-5-PYRIMIDINECARBOXYLIC ACID
1-(5,8-dimethoxy-3,4-dihydronaphthalen-2-yl)ethanone
2-piperazin-1-yl-5-(trifluoromethyl)pyrimidine
C9H11F3N4 (232.09357619999997)
(3-BENZO[1,3]DIOXOL-5-YLMETHYL-3H-IMIDAZOL-4-YL)-METHANOL
5-(2-METHOXY-PHENYL)-2H-PYRAZOLE-3-CARBOXYLIC ACID METHYL ESTER
(S)-1-(TERT-BUTOXYCARBONYL)-4,4-DIFLUOROPYRROLIDINE-2-CARBOXYLICACID
BENZOTRIAZOL-1-YLPYRROLIDIN-1-YLMETHANE&
C11H12N4S (232.07826319999998)
di-tert-butylphosphate, sodium salt
C8H18NaO4P (232.08403579999998)
2-Naphthalenebutanoicacid, 5,6,7,8-tetrahydro-g-oxo-
2-(3-(4-Methoxyphenyl)-1H-pyrazol-1-yl)acetic acid
1-(2-methylphenyl)-4-oxocyclohexane-1-carboxylic acid
Seletracetam
C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent C26170 - Protective Agent > C1509 - Neuroprotective Agent
Rezatomidine
C13H16N2S (232.10341359999998)
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist
Ethyl 8-methyl-4-oxo-4H-pyrido[1,2-a]pyrimidine-3-carboxylate
Ethyl 6-methyl-4-oxopyrido[1,2-a]pyrimidine-3-carboxylate
1,1,1,2,2-Pentamethyl-2-(phenylethynyl)disilane
C13H20Si2 (232.11034800000002)
Ethyl 9-methyl-4-oxopyrido[1,2-a]pyrimidine-3-carboxylate
4H-Pyrido[1,2-a]pyrimidine-3-acetic acid, 4-oxo-, ethyl ester
2-Propenoic acid, 3-ethoxy-3-[(trimethylsilyl)oxy]-, ethyl ester
C10H20O4Si (232.11308000000002)
(S)-2-((S)-2-Amino-3-methylbutanamido)succinic acid
(Z)-2-(5-methylsulfanylpentyl)but-2-enedioic acid
C10H16O4S (232.07692559999998)
4-Amino-5-(4-aminobutanoyloxy)-5-oxopentanoic acid
N-[5-(2-methoxyphenyl)-1H-1,2,4-triazol-3-yl]acetamide
5-methyl-N-(3-methylphenyl)-4-nitro-1H-pyrazol-3-amine
1-(3,4-Dihydroxyphenyl)-2-(2-methyl-1-imidazolyl)ethanone
1-(3,4-Dihydroxyphenyl)-2-(4-methyl-1-pyrazolyl)ethanone
2-methyl-N-[(E)-(5-methylfuran-2-yl)methylidene]furan-3-carbohydrazide
(2S)-2-amino-5-[(2S)-2-aminobutanoyl]oxy-5-oxopentanoic acid
(2R,3R)-2-[(3S,6R)-3-Amino-6-hydroxy-2-oxopiperidinyl]-3-hydroxybutanoic acid
(2S,3R)-2-amino-3-hydroxy-5-[(2S,4R)-4-hydroxypyrrolidin-2-yl]-5-oxopentanoic acid
Glutaric acid, ethyltrimethylsilyl ester
C10H20O4Si (232.11308000000002)
6,6-Dimethyl-3h-spiro[2-benzofuran-1,2-oxane]-3-one
Cryptolepine
An organic heterotetracyclic compound that is 5H-indolo[3,2-b]quinoline in which the hydrogen at position N-5 is replaced by a methyl group. D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents
N-(indol-3-ylacetyl)glycine
An N-acylglycine in which the N-acyl group is specified as indol-3-ylacetyl.
geranyl phosphate(2-)
An organophosphate oxoanion obtained by deprotonation of the phosphate OH groups of geranyl phosphate; major species at pH 7.3.
4-(L-gamma-glutamylamino)Butanoic acid
An N-acyl-gamma-aminobutyric acid resulting from the formal condensation of the amino group of 4-aminobutanoic acid with the gamma-carbxy group of L-glutamic acid.
Drupanin
Drupanin is a compound isolated from green propolis. Drupanin can selectively inhibit the AKR1C3 enzyme. Drupanin has the potential for the research of breast cancer[1].
3-[4-hydroxy-3-(3-methylbut-2-en-1-yl)phenyl]prop-2-enoic acid
6,7-dihydroxy-7-(hydroxymethyl)-5-methoxy-hexahydrocyclopenta[c]pyran-3-one
(2s,3r,5z)-5-ethylidene-2-hydroxy-2-(hydroxymethyl)-3-methylhexanedioic acid
3-(penta-1,3-dien-1-yl)-3,4-dihydro-1h-2-benzopyran-4,8-diol
(2e,4e)-1-(2-hydroxy-4-methoxy-5-methylphenyl)hexa-2,4-dien-1-one
9-methoxy-2,10-dioxatricyclo[5.3.1.0⁴,¹¹]undecane-4,5,6-triol
1-[(2r)-6-methoxy-2-(prop-1-en-2-yl)-2,3-dihydro-1-benzofuran-5-yl]ethanone
(3r,3ar)-3-(furan-3-yl)-3a,7-dimethyl-3,4,5,7a-tetrahydro-2-benzofuran-1-one
(4s)-4-hydroxy-3-[2-(4-hydroxyphenyl)ethyl]cyclohex-2-en-1-one
5,10-dimethyl-3-oxatetracyclo[7.4.0.0¹,¹⁰.0²,⁶]tridec-12-ene-4,11-dione
(3r,4e,6e,12e)-tetradeca-4,6,12-trien-8,10-diyne-1,3,14-triol
(3r)-3-hydroxy-7-methoxy-1h,2h,3h-pyrrolo[2,1-b]quinazolin-9-one
1-[5-methoxy-2-(prop-1-en-2-yl)-2,3-dihydro-1-benzofuran-4-yl]ethanone
atractylentriol
{"Ingredient_id": "HBIN017289","Ingredient_name": "atractylentriol","Alias": "NA","Ingredient_formula": "C14H16O3","Ingredient_Smile": "C(CO)C(C=CC=CC#CC#CC=CCO)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14416","TCMID_id": "1968","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(3z,6z)-deca-3,6,9-trien-1-yloxysulfonic acid
C10H16O4S (232.07692559999998)
(2r)-7-hydroxy-6,8-dimethyl-2-[(1e)-prop-1-en-1-yl]-2,3-dihydro-1-benzopyran-4-one
7-hydroxy-6,8-dimethyl-2-(prop-1-en-1-yl)-2,3-dihydro-1-benzopyran-4-one
(3r)-3-hydroxy-5-methoxy-1h,2h,3h-pyrrolo[2,1-b]quinazolin-9-one
3-hydroxy-5-methoxy-1h,2h,3h-pyrrolo[2,1-b]quinazolin-9-one
(2s)-2-amino-4-[(3-carboxypropyl)-c-hydroxycarbonimidoyl]butanoic acid
(2e,4e)-1-(2,6-dihydroxy-3,5-dimethylphenyl)hexa-2,4-dien-1-one
(3'r,4r)-1,3'-dihydroxyspiro[2,7-naphthyridine-4,1'-cyclopentan]-3-one
4,6-dimethoxy-2-methyl-3-(3-methylbut-3-en-1-yn-1-yl)phenol
2-hydroxy-6-[(1e,3s)-4-hydroxy-3-[(1e)-prop-1-en-1-yl]but-1-en-1-yl]benzaldehyde
n-[(1s)-1-hydroxy-2-(1h-indol-3-yl)-2-oxoethyl]ethanimidic acid
(3ar,8ar,9ar)-8a-methyl-3-methylidene-3ah,6h,7h,8h,9h,9ah-naphtho[2,3-b]furan-2,5-dione
(2e)-3-(2,2-dimethyl-3,4-dihydro-1-benzopyran-6-yl)prop-2-enoic acid
(3ar,8s,9as)-8-methyl-3-methylidene-3ah,4h,6h,7h,8h,9h,9ah-azuleno[6,5-b]furan-2,5-dione
6-[(1e,3e,5e)-hepta-1,3,5-trien-1-yl]-4-methoxy-5-methylpyran-2-one
2-hydroxy-6-[4-hydroxy-3-(prop-1-en-1-yl)but-1-en-1-yl]benzaldehyde
1-(2,4-dihydroxy-3,5-dimethylphenyl)hexa-2,4-dien-1-one
2-hydroxy-6-[(1e,3r)-4-hydroxy-3-[(1e)-prop-1-en-1-yl]but-1-en-1-yl]benzaldehyde
6-(hydroxymethyl)-6,8-dimethyl-3h,5h,7h-indeno[5,6-c]furan-1-one
10-hydroxy-5,8-dimethyl-9-methylidene-12-oxatetracyclo[6.4.0.0¹,¹¹.0³,⁷]dodec-4-en-6-one
3-(2,5-dihydroxy-4-methylphenyl)-4,4-dimethylcyclopent-2-en-1-one
3-[(3r)-3-hydroxy-2,2-dimethyl-3,4-dihydro-1-benzopyran-6-yl]prop-2-enal
3-[(1e,3e)-penta-1,3-dien-1-yl]-3,4-dihydro-1h-2-benzopyran-4,8-diol
6-(hepta-1,3,5-trien-1-yl)-4-methoxy-5-methylpyran-2-one
1-(5-acetyl-2-methoxyphenyl)-3-methylbut-2-en-1-one
(2z)-3-[4-hydroxy-3-(3-methylbut-2-en-1-yl)phenyl]prop-2-enoic acid
1-(2-hydroxy-4-methoxy-5-methylphenyl)hexa-2,4-dien-1-one
{n'-[(2s)-1-methoxy-4-methyl-1-oxopentan-2-yl]hydrazinecarbonyl}formic acid
1-[6-methoxy-2-(prop-1-en-2-yl)-2,3-dihydro-1-benzofuran-5-yl]ethanone
(2s,3s,5e)-5-ethylidene-2-hydroxy-2-(hydroxymethyl)-3-methylhexanedioic acid
(3s,4r)-3-[(1e,3e)-penta-1,3-dien-1-yl]-3,4-dihydro-1h-2-benzopyran-4,8-diol
(1s)-1,7-dihydroxy-4-isopropyl-1-methylnaphthalen-2-one
1-[(2r)-5-methoxy-2-(prop-1-en-2-yl)-2,3-dihydro-1-benzofuran-4-yl]ethanone
4-hydroxy-3-[2-(4-hydroxyphenyl)ethyl]cyclohex-2-en-1-one
5-hydroxy-3-[2-(4-hydroxyphenyl)ethyl]cyclohex-2-en-1-one
8-methyl-3-methylidene-3ah,4h,6h,7h,8h,9h,9ah-azuleno[6,5-b]furan-2,5-dione
deca-3,6,9-trien-1-yloxysulfonic acid
C10H16O4S (232.07692559999998)
(4ar,8ar,9as)-3,8a-dimethyl-4h,4ah,5h,9h,9ah-naphtho[2,3-b]furan-2,8-dione
8-methyl-3-methylidene-3ah,4h,4ah,7ah,8h,9h,9ah-azuleno[6,5-b]furan-2,5-dione
3-[(2r,5r)-5-(furan-2-ylmethyl)-5-methyloxolan-2-yl]furan
7-hydroxy-1h,2h,3h,4h,9h-pyrido[3,4-b]indole-3-carboxylic acid
(6r)-6-(hydroxymethyl)-6,8-dimethyl-3h,5h,7h-indeno[5,6-c]furan-1-one
(4s,6s,9s)-9-methoxy-2,10-dioxatricyclo[5.3.1.0⁴,¹¹]undecane-4,5,6-triol
(2s)-5-amino-2-[(3-carboxy-1-hydroxypropylidene)amino]pentanoic acid
1-[6-methoxy-2-(prop-1-en-2-yl)-1-benzofuran-5-yl]ethanol
8-hydroxy-4,7,7-trimethyl-3h,6h,8h-indeno[4,5-c]furan-1-one
10-(methylsulfanyl)-2-oxodecanoic acid
C11H20O3S (232.11330900000002)